Rydex Health Care C (RYHCX)
Fund Assets | 29.43M |
Expense Ratio | 2.40% |
Min. Investment | $2,500 |
Turnover | 236.00% |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | n/a |
Previous Close | 89.28 |
YTD Return | 2.58% |
1-Year Return | -7.71% |
5-Year Return | 21.35% |
52-Week Low | 78.93 |
52-Week High | 95.88 |
Beta (5Y) | 0.72 |
Holdings | 129 |
Inception Date | Mar 30, 2001 |
About RYHCX
Rydex Health Care Fund Class C is a sector-focused mutual fund specializing in investments within the U.S. healthcare industry. Its primary objective is to achieve capital preservation and appreciation by allocating its portfolio predominantly to companies involved in healthcare, including pharmaceuticals, biotechnology, medical equipment, and related services. The fund offers exposure to an industry known for its defensive characteristics and ongoing innovation, serving investors seeking to participate in the healthcare sector's growth. With total assets of approximately $19.2 million and an expense ratio of around 2.38%, the fund is actively managed to navigate the unique challenges and opportunities presented by this dynamic sector. Rydex Health Care Fund Class C plays a specialized role in the financial markets by providing targeted access to healthcare equities, catering to investors who wish to diversify their portfolios or focus on health-related themes without directly purchasing individual stocks.
Performance
RYHCX had a total return of -7.71% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.87%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
26.17% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 3.93% |
First American Government Obligations Fund | FGXXX | 3.12% |
Johnson & Johnson | JNJ | 2.97% |
AbbVie Inc. | ABBV | 2.78% |
UnitedHealth Group Incorporated | UNH | 2.59% |
Abbott Laboratories | ABT | 2.39% |
Intuitive Surgical, Inc. | ISRG | 2.26% |
Merck & Co., Inc. | MRK | 2.15% |
Boston Scientific Corporation | BSX | 2.07% |
Thermo Fisher Scientific Inc. | TMO | 1.90% |